
377: Melodrama at the FDA and the Pfizer-Novo bidding war
The Readout Loud
00:00
What does this turmoil mean for the FDA's reputation?
Lizzy and Adam reflect on public reactions, investor embarrassment, and risks to regulatory stability and patient access.
Play episode from 20:56
Transcript


